| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 9 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HI15
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.545 |
| CLV_NRD_NRD_1 | 164 | 166 | PF00675 | 0.575 |
| CLV_NRD_NRD_1 | 193 | 195 | PF00675 | 0.502 |
| CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.575 |
| CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.543 |
| CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.682 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.589 |
| DOC_MAPK_gen_1 | 164 | 171 | PF00069 | 0.564 |
| DOC_MAPK_JIP1_4 | 165 | 171 | PF00069 | 0.598 |
| DOC_PP2B_LxvP_1 | 160 | 163 | PF13499 | 0.537 |
| DOC_PP2B_PxIxI_1 | 183 | 189 | PF00149 | 0.464 |
| DOC_USP7_MATH_1 | 121 | 125 | PF00917 | 0.692 |
| DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.546 |
| LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.604 |
| LIG_14-3-3_CanoR_1 | 60 | 66 | PF00244 | 0.410 |
| LIG_AP2alpha_2 | 196 | 198 | PF02296 | 0.511 |
| LIG_BRCT_BRCA1_1 | 15 | 19 | PF00533 | 0.574 |
| LIG_FHA_1 | 15 | 21 | PF00498 | 0.561 |
| LIG_FHA_2 | 187 | 193 | PF00498 | 0.476 |
| LIG_LIR_Nem_3 | 127 | 132 | PF02991 | 0.482 |
| LIG_LIR_Nem_3 | 51 | 56 | PF02991 | 0.521 |
| LIG_NRBOX | 96 | 102 | PF00104 | 0.553 |
| LIG_Pex14_2 | 59 | 63 | PF04695 | 0.389 |
| LIG_REV1ctd_RIR_1 | 115 | 123 | PF16727 | 0.659 |
| LIG_REV1ctd_RIR_1 | 50 | 58 | PF16727 | 0.549 |
| LIG_SH2_CRK | 80 | 84 | PF00017 | 0.501 |
| LIG_SH2_NCK_1 | 125 | 129 | PF00017 | 0.483 |
| LIG_SH2_STAP1 | 125 | 129 | PF00017 | 0.483 |
| LIG_SH2_STAP1 | 75 | 79 | PF00017 | 0.399 |
| LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.446 |
| LIG_SH3_3 | 150 | 156 | PF00018 | 0.503 |
| LIG_SH3_3 | 160 | 166 | PF00018 | 0.595 |
| LIG_SH3_3 | 55 | 61 | PF00018 | 0.543 |
| MOD_CK1_1 | 124 | 130 | PF00069 | 0.735 |
| MOD_CK2_1 | 186 | 192 | PF00069 | 0.474 |
| MOD_Cter_Amidation | 101 | 104 | PF01082 | 0.594 |
| MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.678 |
| MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.616 |
| MOD_GSK3_1 | 120 | 127 | PF00069 | 0.689 |
| MOD_GSK3_1 | 143 | 150 | PF00069 | 0.540 |
| MOD_GSK3_1 | 3 | 10 | PF00069 | 0.614 |
| MOD_GSK3_1 | 61 | 68 | PF00069 | 0.414 |
| MOD_N-GLC_1 | 14 | 19 | PF02516 | 0.585 |
| MOD_NEK2_1 | 13 | 18 | PF00069 | 0.560 |
| MOD_PK_1 | 3 | 9 | PF00069 | 0.643 |
| MOD_Plk_1 | 144 | 150 | PF00069 | 0.429 |
| MOD_Plk_4 | 3 | 9 | PF00069 | 0.604 |
| MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.536 |
| TRG_DiLeu_BaLyEn_6 | 89 | 94 | PF01217 | 0.513 |
| TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.421 |
| TRG_ENDOCYTIC_2 | 85 | 88 | PF00928 | 0.404 |
| TRG_ER_diArg_1 | 163 | 165 | PF00400 | 0.582 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P7F0 | Leptomonas seymouri | 78% | 100% |
| A0A0S4JPS5 | Bodo saltans | 37% | 100% |
| A0A1X0P291 | Trypanosomatidae | 56% | 100% |
| A0A3S7X362 | Leishmania donovani | 88% | 100% |
| A0A422NIE5 | Trypanosoma rangeli | 57% | 100% |
| A4I592 | Leishmania infantum | 88% | 100% |
| C9ZQM3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
| E9B0I9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
| Q4Q7Q9 | Leishmania major | 86% | 100% |